The Institutional Pivot: Why Federal Heavyweights Are Flocking to a 179-Year-Old Medical Academy

NEW YORK, NY – October 15, 2026 – The center of gravity in American healthcare policy is quietly shifting. For decades, the structural changes that defined the medical marketplace—from value-based care algorithms to sweeping population health mandates—were exclusively engineered within the labyrinthine corridors of federal agencies. Today, however, the architects of those very systems are finding a new, more agile laboratory for disruption: the regional, independent medical academy.

This strategic migration was starkly illuminated today when the New York Academy of Medicine announced its 2026 cohort of Senior Scholars. The newly appointed group reads like a who’s who of federal and academic healthcare administration, featuring top-tier veterans from the National Institutes of Health, the Veterans Health Administration, and the Agency for Healthcare Research and Quality. By convening this specific mix of talent, the 179-year-old institution is signaling a bold pivot, positioning itself not merely as a historic convening body, but as a primary engine for translating high-level policy into block-by-block urban health interventions.

Bypassing the Bureaucracy: The Federal Exodus

To understand the strategic rationale behind this cohort, one must look at the structural bottlenecks currently plaguing national public health apparatuses. As federal funding for expansive public health programs faces increasing political headwinds, policy implementation has slowed. In response, visionary leaders are seeking out non-profit, community-embedded organizations that possess the flexibility to test and scale interventions rapidly.

Dr. Carolyn Clancy and Dr. Robert Kaplan perfectly embody this transition. Dr. Clancy’s resume is a testament to federal scale. As the current Assistant Under Secretary for Health for the Office of Discovery, Education & Affiliate Networks within the Veterans Health Administration, and the former director of the Agency for Healthcare Research and Quality, she has spent her career shaping national policies on patient safety and health equity for millions of veterans. Joining her is Dr. Kaplan, a pioneer in behavioral medicine who previously served as Chief Science Officer at AHRQ and Associate Director at the NIH. Currently a Senior Advisor for ARPA-H and faculty at Stanford’s Clinical Excellence Research Center, his work has fundamentally altered how the industry measures patient-reported outcomes and health-related quality of life.

Their involvement with a regional academy underscores a critical industry realization: the next era of healthcare disruption will not be dictated by sweeping federal mandates, but by localized, data-driven pilot programs. As one prominent health policy analyst noted recently, massive federal agencies are built for stability, not speed; to iterate on new care distribution models, leaders need the operational agility that only independent institutions can provide.

An Interdisciplinary Strike Team for Urban Health

Beyond the federal pedigree, the 2026 cohort is notable for its aggressive cross-pollination of disciplines. The modern medical crisis is rarely confined to a single vector; issues like maternal mortality and pandemic preparedness require a synthesis of clinical surgery, nursing, behavioral science, and administrative scale.

Dr. Joseph Kerschner brings the necessary academic and operational scaling expertise to the table. Having recently transitioned from a 14-year tenure as Dean and inaugural Provost at the Medical College of Wisconsin to a role as a Strategic Transformation Senior Partner at Chartis, Dr. Kerschner understands the complex machinery of medical education and clinical innovation. His background in shaping national academic medicine policy through the Association of American Medical Colleges provides the cohort with a blueprint for how to train the next generation of physicians to operate in a value-based paradigm.

Grounding this administrative and policy expertise in frontline implementation is Dr. Elaine Larson. An internationally recognized leader in infection prevention, Dr. Larson is the Anna C. Maxwell Professor Emerita at Columbia University. With over 400 scientific publications, her pioneering research on hand hygiene and healthcare-associated infections is critical in a post-pandemic landscape. As the Chair of the Academy’s Institutional Review Board, she bridges the gap between theoretical policy and evidence-based nursing practice.

“At New York Academy of Medicine, our mission is to ensure that science translates into healthier, longer lives for all,” said Ann Kurth, PhD, CNM, MPH, the president of the organization. “At a time of dynamic change, these distinguished thinkers will help illuminate innovative ways forward, bringing the insight needed to help define the next century of health.”

The Modernization of a Legacy Institution

The appointment of this high-profile cohort also highlights how century-old institutions are successfully reinventing themselves to address modern urban disparities. Founded nearly 180 years ago, the Academy could have easily remained a passive repository of medical history, relying on its world-class library and network of nearly 2,000 elected Fellows. Instead, it has actively aligned its strategic priorities with the most pressing legislative and public health agendas of the 21st century.

This modernization is particularly relevant given the current municipal landscape in New York. Recently, the city council mandated the development of a comprehensive five-year population health agenda aimed at extending the average life expectancy of New Yorkers to 83 years by 2030. Achieving this ambitious target requires dismantling deeply entrenched health inequities, particularly chronic diseases and the alarming rates of maternal mortality that disproportionately affect Black women in boroughs like Brooklyn.

By bringing in scholars who have navigated the complexities of the NIH and the VHA, the organization is arming itself with the exact intellectual capital needed to advise on and execute this municipal mandate. The institution is effectively positioning itself as an outsourced, highly specialized brain trust for urban health reform, bridging the gap between academic research and city-level public health interventions.

Translating Policy into Block-by-Block Reality

Ultimately, the true metric of success for this cohort will not be the publication of academic white papers, but the demonstrable impact on community healthspan. The two-year program is explicitly designed to spark new ideas, strengthen research, and accelerate projects that generate real-world impact.

This requires a departure from traditional, siloed medical research. The future of competition in the healthcare sector is increasingly defined by how effectively organizations can integrate social determinants of health into standard clinical workflows. Whether it is addressing the climate resilience of urban neighborhoods or restructuring maternal care pathways to eliminate racial disparities, the challenges are inherently interdisciplinary.

The 2026 Senior Scholars represent a structural acknowledgment of this new reality. By combining Dr. Kaplan’s behavioral metrics, Dr. Clancy’s federal quality standards, Dr. Kerschner’s academic scaling, and Dr. Larson’s frontline implementation science, the organization has assembled a formidable engine for change. As the healthcare industry continues to fracture and evolve under the weight of technological disruption and shifting economic realities, this model of localized, high-powered collaboration may well become the definitive blueprint for the future of public health.